Schödel Johannes, Padmapriya P, Marx Alexander, Huang Paul L, Ertl Georg, Kuhlencordt Peter J
Medizinische Klinik und Poliklinik I, Universitätsklinikum, Julius-Maximilians-Universität Würzburg, Germany.
Atherosclerosis. 2009 Oct;206(2):383-9. doi: 10.1016/j.atherosclerosis.2009.02.033. Epub 2009 Mar 14.
We previously reported that deletion of brain type neuronal nitric oxide synthase-alpha (nNOS-alpha) accelerates atherosclerosis in apolipoproteinE (apoE) knockout (ko) mice. The regulation of nNOS expression is complex, involving the generation of mRNA splice variants. The current study investigates occurrence and distribution of nNOS variants in atherosclerotic lesions of apoE ko and apoE/nNOS-alpha double ko (dko) animals.
Mice were fed a high fat diet for 20 weeks. Immunohistochemistry and western blot analysis were performed using antibodies detecting the carboxy terminal-, or amino terminal-residue of the nNOS protein. Confocal microscopy and in situ hybridization were used to identify the compartment of cellular expression.
In situ hybridization revealed the presence of nNOS-alpha and -gamma mRNA variants in apoE ko plaques, while only nNOS-gamma was detectable in apoE/nNOS dko plaques. Consistent with mRNA expression nNOS-alpha protein can be detected in the neointima of apoE ko, but not apoE/nNOS dko animals. In contrast, the carboxy terminal antibody stained the neointima and media in apoE ko vessels and showed residual nNOS immunoreactivity in apoE/nNOS dko lesions. Confocal microscopy showed predominant nNOS expression in vascular smooth muscle cells, while colocalization with macrophages was less pronounced.
Our study shows that nNOS-alpha and -gamma splice variants are expressed in atherosclerotic plaques of apoE ko mice. nNOS variants colocalized with markers for vascular smooth muscle cells and macrophages but not for endothelial cells. Since nNOS-alpha is atheroprotective, other nNOS splice variants which differ in enzyme kinetic and subcellular localization may also influence plaque formation.
我们之前报道过,脑型神经元型一氧化氮合酶-α(nNOS-α)的缺失会加速载脂蛋白E(apoE)基因敲除(ko)小鼠的动脉粥样硬化进程。nNOS表达的调控较为复杂,涉及mRNA剪接变体的产生。本研究调查了nNOS变体在apoE基因敲除小鼠和apoE/nNOS-α双基因敲除(dko)动物动脉粥样硬化病变中的发生情况和分布。
给小鼠喂食高脂饮食20周。使用检测nNOS蛋白羧基末端或氨基末端残基的抗体进行免疫组织化学和蛋白质印迹分析。利用共聚焦显微镜和原位杂交来确定细胞表达的区域。
原位杂交显示apoE基因敲除小鼠斑块中存在nNOS-α和-γ mRNA变体,而在apoE/nNOS双基因敲除斑块中仅可检测到nNOS-γ。与mRNA表达一致,在apoE基因敲除小鼠的内膜中可检测到nNOS-α蛋白,而在apoE/nNOS双基因敲除动物中则未检测到。相比之下,羧基末端抗体在apoE基因敲除小鼠血管的内膜和中膜中染色,并且在apoE/nNOS双基因敲除病变中显示出残留的nNOS免疫反应性。共聚焦显微镜显示nNOS在血管平滑肌细胞中主要表达,而与巨噬细胞的共定位则不太明显。
我们的研究表明,nNOS-α和-γ剪接变体在apoE基因敲除小鼠的动脉粥样硬化斑块中表达。nNOS变体与血管平滑肌细胞和巨噬细胞的标志物共定位,但与内皮细胞的标志物不共定位。由于nNOS-α具有抗动脉粥样硬化作用,其他在酶动力学和亚细胞定位方面不同的nNOS剪接变体也可能影响斑块形成。